Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. usa minnesota
  4. fetal
Show results for
Products

Companies


Refine by
Locations
Back to All Locations

  • USA
  • Minnesota
Brands

  • adcirca
  • durepair
  • tyvaso
  • unituxin

Fetal Equipment Supplied In Usa Minnesota

4 equipment items found
In MinnesotaAvailable In MinnesotaNear Minnesota

Durepair - Regeneration Matrix Repair Mater

Durepair - Regeneration Matrix Repair Mater

Manufactured by:Medtronic   based inMinneapolis, MINNESOTA (USA)
Durepair Regeneration Matrix is a non-synthetic dura substitute used to repair defects in the ...
CONTACT SUPPLIER

TYVASO - Treprostinil Inhalation Solution

TYVASO - Treprostinil Inhalation Solution

Manufactured by:United Therapeutics Corporation   based inSilver Spring, MARYLAND (USA)
TYVASO (treprostinil) is a prostacyclin mimetic indicated for the treatment of: Pulmonary arterial hypertension (PAH; WHO Group 1) to improve exercise ability. Studies establishing effectiveness predominately included patients with NYHA Functional Class III symptoms and etiologies of idiopathic or heritable PAH (56%) or PAH associated with connective tissue diseases (33%). The effects diminish ...
CONTACT SUPPLIER

Unituxin - Dinutuximab Injection

Unituxin - Dinutuximab Injection

Manufactured by:United Therapeutics Corporation   based inSilver Spring, MARYLAND (USA)
Unituxin is a GD2-binding monoclonal antibody indicated, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality ...
CONTACT SUPPLIER

Adcirca - Tadalafil Tablets

Adcirca - Tadalafil Tablets

Manufactured by:United Therapeutics Corporation   based inSilver Spring, MARYLAND (USA)
Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients with NYHA Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT